BOSTON, March 30, 2026 -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not...
Scott Weiner will speak about Pappas Ventures' perspective on the Medtech market at the IN3 West: Investment in Innovation Conference in Las Vegas, NV.
News | 02. 22. 2011
